MedTrace Logo

Acostream Use in Patients With High Risk and Intermediate-risk Acute Pulmonary Embolism

NCT06946732 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 127

Last updated 2025-04-27

No results posted yet for this study

Summary

The registry is to evaluate the safety and feasibility of catheter-directed aspiration for patients with high-risk and intermediate-high-risk pulmonary embolism using Acostream.

Conditions

  • Pulmonary Embolism (PE)

Interventions

DEVICE

Acostream aspiration

The pulmonary thrombus removal by Acostream.

Sponsors & Collaborators

  • Xiamen Cardiovascular Hospital, Xiamen University

    collaborator OTHER

  • Nantong University Affiliated Hospital

    collaborator UNKNOWN

  • Chengdu University of Traditional Chinese Medicine

    collaborator OTHER

  • Shanghai No.1 Hospital

    collaborator UNKNOWN

  • First Affiliated Hospital of Fujian Medical University

    collaborator OTHER

  • Jinhua Central Hospital

    collaborator OTHER

  • RenJi Hospital

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-01
Primary Completion
2025-12-31
Completion
2026-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06946732 on ClinicalTrials.gov